Picture of IRLAB Therapeutics AB logo

IRLAB A — IRLAB Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: IRLAB Resolves On Rights Issue, Obtains Extended Loan Financing

May 5 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:

IRLAB RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK 68 MILLION WITH AN OVERALLOTMENT ISSUE AND OBTAINS EXTENDED LOAN FINANCING

EXTENDS SEK 18.5 MILLION OF SEK 23.7 MILLION LOAN FROM FENJA CAPITAL TO NOV 30, 2027

EXTRAORDINARY GENERAL MEETING TO APPROVE RIGHTS ISSUE AND OVERALLOTMENT ISSUE ON JUNE 5, 2026

BOARD RESOLVES ON OVERALLOTMENT ISSUE OF UP TO ABOUT SEK 33.8 MILLION

Source text: ID:nMFNRLdgF

Further company coverage: [IRLABa.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on IRLAB Therapeutics AB

See all news